Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)-China Extension

Clinical trial NCT04859582 · WITHDRAWN

Trial details

NCT number: NCT04859582
Sponsor: Merck Sharp & Dohme LLC
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Stomach Neoplasms

Start date: 2018-11-08
Primary completion: 2024-11-29
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.